|
|
.
See Category: Neoplasms
See Header: Secondary carcinoid tumors
ICD-10 (CM) Code and Descriptor
|
C7B.02 |
Secondary carcinoid tumors of liver
|
C7B02 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 24.09%
|
42.39%
|
16.93%
|
6.59%
|
3.29%
|
2.59%
|
1.71%
|
0.89%
|
0.52%
|
0.31%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C7B.02*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
1,805
|
1,954
|
|
80053
|
COMPREHEN METABOLIC PANEL |
1,623
|
1,623
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
1,483
|
1,483
|
|
J2353
|
OCTREOTIDE INJECTION, DEPOT |
1,377
|
41,861
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
1,310
|
1,314
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
1,160
|
1,163
|
|
86316
|
IMMUNOASSAY TUMOR OTHER |
770
|
775
|
|
J1930
|
LANREOTIDE INJECTION |
578
|
68,761
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
467
|
46,603
|
|
85610
|
PROTHROMBIN TIME |
248
|
248
|
|
G1004
|
CDSM NDSC |
222
|
265
|
|
84260
|
ASSAY OF SEROTONIN |
213
|
213
|
|
83735
|
ASSAY OF MAGNESIUM |
206
|
206
|
|
J3010
|
FENTANYL CITRATE INJECTION |
200
|
437
|
|
J2405
|
ONDANSETRON HCL INJECTION |
199
|
1,543
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
189
|
189
|
|
85027
|
COMPLETE CBC AUTOMATED |
185
|
186
|
|
78815
|
PET IMAGE W/CT SKULL-THIGH |
181
|
181
|
|
71260
|
CT THORAX DX C+ |
175
|
175
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
174
|
466
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C7B.02 related to the following DRG Codes:
435-437
|
